Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Historical Holders from Q3 2024 to Q4 2024

Symbol
MNPR on Nasdaq
CUSIP
61023L207
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
6.26M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
2.58M
Holdings value
$57.1M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
18
Number of buys
14
Number of sells
-1
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 17.2% $42.2M 1.05M JANUS HENDERSON GROUP PLC Dec 31, 2024
Monopar Therapeutics 13.4% $28.4M 705K Hendricks Diane Dec 9, 2024
RA CAPITAL MANAGEMENT, L.P. 9.9% $25M 620K RA Capital Management, L.P. Dec 31, 2024
Adage Capital Management, L.P. 9.86% $24.2M 599K Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 2.58M $57.1M +$56.8M $22.00 18
2024 Q3 15.7K $106K +$106K $6.74 6